Page last updated: 2024-08-25

ketorolac tromethamine and Anemia, Sickle Cell

ketorolac tromethamine has been researched along with Anemia, Sickle Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burt, R; Castro, O; Finke, H; McHugh, D; Perlin, E; Pittman, J; Rana, S; Ruff, C1
Adamkiewicz, T; Beiter, JL; Chambliss, CR; Simon, HK; Sullivan, K1

Trials

1 trial(s) available for ketorolac tromethamine and Anemia, Sickle Cell

ArticleYear
Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis.
    American journal of hematology, 1994, Volume: 46, Issue:1

    Topics: Adult; Analgesics; Anemia, Sickle Cell; Constriction, Pathologic; Digestive System Diseases; Double-Blind Method; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Ketorolac Tromethamine; Male; Meperidine; Pain Measurement; Palliative Care; Placebos; Tolmetin; Tromethamine; Vascular Diseases

1994

Other Studies

1 other study(ies) available for ketorolac tromethamine and Anemia, Sickle Cell

ArticleYear
Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
    Archives of pediatrics & adolescent medicine, 2001, Volume: 155, Issue:4

    Topics: Adolescent; Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Child; Emergencies; Female; Humans; Infusions, Intravenous; Ketorolac Tromethamine; Likelihood Functions; Male; Pain; Patient Selection; Prospective Studies; Severity of Illness Index

2001